SCHEMBL8095544

SCHEMBL8095544

C=CCC1(CC=C)CCSc2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
GSK3B P49841 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7676307 0.78 BACE1 (0.33)
SCHEMBL4906291 0.78 SIGMAR1 (0.35) MEN1KMT2A
SCHEMBL7674394 0.75 RARA (0.31) KMT2A
SCHEMBL7938518 0.71 GSK3B (0.33) MEN1KMT2AGSK3B
SCHEMBL7675030 0.70 RARA (0.39) KMT2A
SCHEMBL29501701 0.70 SIGMAR1 (0.43)
SCHEMBL9281778 0.68 SIGMAR1 (0.51) MEN1KMT2A
SCHEMBL5173680 0.68 RARA (0.32) MEN1KMT2A
SCHEMBL20921350 0.67 MEN1 (0.34) MEN1KMT2A
SCHEMBL1649848 0.67 RARA (0.40) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0740665-B1 PROCESS FOR PREPARING 4,4-DIALKYL-6-HALO-CHROMANS OR THIOCHROMANS USEFUL AS PHARMACEUTICAL INTERMEDIATES ALLERGAN SALES INC (US) 2000-12-06 EP disclosed
EP-0740665-A1 PROCESS FOR PREPARING 4,4-DIALKYL-6-HALO-CHROMANS OR THIOCHROMANS USEFUL AS PHARMACEUTICAL INTERMEDIATES Allergan (US) 1996-11-06 EP disclosed
US-5519150-A Process for preparing 4,4-dialkyl-6-halo-chromans or thiochromans useful as pharmaceutical intermediates ALLERGAN (US) 1996-05-21 US disclosed
WO-1995019973-A2 PROCESS FOR PREPARING 4,4-DIALKYL-6-HALO-CHROMANS OR THIOCHROMANS USEFUL AS PHARMACEUTICAL INTERMEDIATES ALLERGAN (US) 1995-07-27 WO disclosed
US-5420295-A Process for preparing 4,4-dialkyl-6-halo-chromans or thiochromans useful as pharmaceutical intermediates ALLERGAN, INC. (US) 1995-05-30 US disclosed